Lv2
180 积分 2022-11-03 加入
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
19天前
已完结
Abscopal effect following combined radiotherapy and immunotherapy in pulmonary metastases
19天前
已关闭
Myasthenia gravis, myositis and myocarditis: a fatal triad of immune-related adverse effect of immune checkpoint inhibitor treatment
19天前
已关闭
Effects of Radiotherapy in Normal Tissue
19天前
已完结
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naive Advanced Hepatocellular Carcinoma: Long-Term Follow-Up of Open-Label, Phase 2 KEYNOTE-224 Study
19天前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
22天前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
24天前
已完结
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII)
1个月前
已完结
Toxic Erythema of Chemotherapy
1个月前
已关闭
皖公网安备34019202002308
